FLT3 ligand enhances the cancer therapeutic potency of naked RNA vaccines.
Kreiter S, Diken M, Selmi A, Diekmann J, Attig S, Hüsemann Y, Koslowski M, Huber C, Türeci Ö, Sahin U.
Kreiter S, et al. Among authors: diken m.
Cancer Res. 2011 Oct 1;71(19):6132-42. doi: 10.1158/0008-5472.CAN-11-0291. Epub 2011 Aug 4.
Cancer Res. 2011.
PMID: 21816907